CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions |
6 Months Ended |
Apr. 30, 2016 |
Apr. 30, 2015 |
| Cash flows from operating activities: |
|
|
| Net income |
$ 214
|
$ 150
|
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|
|
| Depreciation and amortization |
130
|
131
|
| Share-based compensation |
36
|
33
|
| Deferred taxes |
35
|
4
|
| Excess and obsolete inventory related charges |
12
|
13
|
| Other non-cash expense, net |
8
|
5
|
| Changes in assets and liabilities: |
|
|
| Accounts receivable |
19
|
16
|
| Inventory |
(13)
|
(18)
|
| Accounts payable |
(53)
|
(35)
|
| Employee compensation and benefits |
(13)
|
(7)
|
| Other assets and liabilities |
(15)
|
(129)
|
| Net cash provided by operating activities |
360
|
163
|
| Cash flows from investing activities: |
|
|
| Investments in property, plant and equipment |
(63)
|
(52)
|
| Proceeds from sale of property, plant and equipment |
0
|
11
|
| Loan to equity method investment |
3
|
0
|
| Payment to acquire cost method investment |
(80)
|
0
|
| Payments to acquire equity method investments |
0
|
(1)
|
| Payment in exchange for convertible note |
(1)
|
0
|
| Change in restricted cash and cash equivalents, net |
245
|
1
|
| Proceeds from sale of investment securities |
1
|
0
|
| Proceeds from divestitures |
0
|
3
|
| Acquisitions of businesses and intangible assets, net of cash acquired |
(235)
|
0
|
| Net cash used in investing activities |
(136)
|
(38)
|
| Cash flows from financing activities: |
|
|
| Issuance of common stock under employee stock plans |
32
|
40
|
| Payment of dividends |
(75)
|
(67)
|
| Net transfer of cash and cash equivalents to Keysight |
0
|
(734)
|
| Proceeds from revolving credit facility |
255
|
0
|
| Repayment of revolving credit facility |
(20)
|
0
|
| Treasury stock repurchases |
(294)
|
(168)
|
| Net cash used in financing activities |
(102)
|
(929)
|
| Effect of exchange rate movements |
14
|
(27)
|
| Net increase (decrease) in cash and cash equivalents |
136
|
(831)
|
| Change in cash and cash equivalents related to discontinued operations |
0
|
810
|
| Cash and cash equivalents at beginning of period |
2,003
|
2,218
|
| Cash and cash equivalents at end of period |
$ 2,139
|
$ 2,197
|